Why does natalizumab treatment for multiple sclerosis increase risk of PML/JC virus reactivation, but not so much other commonly found CNS pathogens?

Just curious because Toxoplasma gondii establishes a latent CNS-infection in a large portion of the world's population and becomes a major concern in immunocompromising conditions such as AIDS,...

13 January 2019 7,218 0 View